Krystal Biotech buy Cantor Fitzgerald
Start price
13.12.23
/
50%
€105.00
Target price
13.12.24
€166.84
Performance (%)
38.24%
Price
25.04.24
€145.15
Summary
This prediction is currently active. With a performance of 38.24% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 13.12.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -2.420% | -2.420% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Cantor Fitzgerald from $160.00 to $180.00. They now have an "overweight" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
40.92%
25.04.24
25.04.24
